• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与蜂窝织炎/丹毒患者住院时间延长相关的临床和实验室因素]

[Clinical and Laboratory Factors Associated with Prolonged Hospital Stay among Patients with Cellulitis/Erysipelas].

作者信息

Roda Ângela, Pinto Ana Marcos, Filipe Ana Rita, Travassos Ana Rita, Freitas João Pedro, Filipe Paulo

机构信息

Serviço de Dermatologia. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. Portugal.

Unidade de Saúde Pública de Oeiras. Agrupamento de Centros de Saúde de Lisboa Ocidental e Oeiras. Oeiras. Portugal.

出版信息

Acta Med Port. 2019 Jun 28;32(6):448-452. doi: 10.20344/amp.10735.

DOI:10.20344/amp.10735
PMID:31292026
Abstract

INTRODUCTION

Cellulitis and erysipelas represent the most frequent cause of hospitalization in the dermatology department of Santa Maria Hospital in Lisbon, Portugal. The aim of this study was to investigate whether patient demographics, comorbidities, previous episodes of cellulitis/erysipelas, the presence of complications, laboratory markers at admission, microbial isolation or previous use of antibiotics, are associated with prolonged stays.

MATERIAL AND METHODS

Retrospective analysis, including patients admitted with cellulitis/erysipelas in the inpatient dermatology department of Santa Maria Hospital between July 1st 2012 and June 30th 2017.

RESULTS

There were 372 admissions, corresponding to 348 patients. The median length of stay was 11 days. Increased age (p = 0.002, OR 1.03, 95% CI 1.01 - 1.04), previous episode of cellulitis/erysipelas requiring hospitalization (p = 0.005, OR 4.81, 95% CI 1.63 - 14.23), the presence of cellulitis/erysipelas-associated complications (p = 0.001, OR 3.28, 95% CI 1.63 - 6.59), leukocytosis (p = 0.049, OR 1.81, 95% CI 1.00 - 3.30), high levels of C-reactive protein (p = 0.035, OR 1.03, 95% CI 1.00 - 1.06) and a positive culture result (p = 0.002, OR 2.59, 95% CI 1.41 - 4.79) were associated with prolonged hospitalization.

DISCUSSION

Prolonged hospitalization for cellulitis/erysipelas is associated with higher costs, additional clinical investigation, invasive treatments, prolonged courses of antibiotic therapy, risk of nosocomial infections, and delayed return to activities of daily living. Thus, the investigation of clinical-laboratory factors associated with prolonged hospitalization for cellulitis / erysipelas is essential and may be useful for the construction of a severity score.

CONCLUSION

The knowledge of the characteristics that are associated with prolonged stay among patients with cellulitis/erysipelas may be relevant to improve health care, by reducing the length of hospital stay and associated risks and costs.

摘要

引言

蜂窝织炎和丹毒是葡萄牙里斯本圣玛丽亚医院皮肤科住院治疗最常见的病因。本研究的目的是调查患者的人口统计学特征、合并症、既往蜂窝织炎/丹毒发作史、并发症的存在情况、入院时的实验室指标、微生物分离情况或既往抗生素使用情况是否与住院时间延长有关。

材料与方法

回顾性分析2012年7月1日至2017年6月30日期间在圣玛丽亚医院皮肤科住院的蜂窝织炎/丹毒患者。

结果

共372例住院病例,涉及348名患者。中位住院时间为11天。年龄增加(p = 0.002,OR 1.03,95% CI 1.01 - 1.04)、既往因蜂窝织炎/丹毒需住院治疗(p = 0.005,OR 4.81,95% CI 1.63 - 14.23)、存在蜂窝织炎/丹毒相关并发症(p = 0.001,OR 3.28,95% CI 1.63 - 6.59)、白细胞增多(p = 0.049,OR 1.81,95% CI 1.00 - 3.30)、高C反应蛋白水平(p = 0.035,OR 1.03,95% CI 1.00 - 1.06)以及培养结果阳性(p = 0.002,OR 2.59,95% CI 1.41 - 4.79)均与住院时间延长有关。

讨论

蜂窝织炎/丹毒住院时间延长会带来更高的费用、额外的临床检查、侵入性治疗、延长抗生素治疗疗程、医院感染风险以及延迟恢复日常生活活动。因此,调查与蜂窝织炎/丹毒住院时间延长相关的临床实验室因素至关重要,可能有助于构建严重程度评分。

结论

了解蜂窝织炎/丹毒患者中与住院时间延长相关的特征,对于通过缩短住院时间以及降低相关风险和成本来改善医疗保健可能具有重要意义。

相似文献

1
[Clinical and Laboratory Factors Associated with Prolonged Hospital Stay among Patients with Cellulitis/Erysipelas].[与蜂窝织炎/丹毒患者住院时间延长相关的临床和实验室因素]
Acta Med Port. 2019 Jun 28;32(6):448-452. doi: 10.20344/amp.10735.
2
[Erysipelas and cellulitis: a retrospective study of 122 cases].[丹毒与蜂窝织炎:122例回顾性研究]
Actas Dermosifiliogr. 2009 Dec;100(10):888-94.
3
Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.丹毒和蜂窝织炎:意大利一家三级护理医院中的临床与微生物学谱
J Infect. 2005 Dec;51(5):383-9. doi: 10.1016/j.jinf.2004.12.010.
4
Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis.住院治疗丹毒和蜂窝织炎的成年患者的临床和流行病学特征。
Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2147-52. doi: 10.1007/s10096-012-1549-2.
5
Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome.对丹毒或蜂窝织炎的抗生素治疗指南的遵循与良好的治疗结果相关。
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):703-709. doi: 10.1007/s10096-019-03490-6. Epub 2019 Jan 26.
6
Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting.美国急诊科成人和儿童蜂窝织炎和丹毒的负担、危险因素和感染并发症。
J Am Acad Dermatol. 2021 May;84(5):1496-1503. doi: 10.1016/j.jaad.2020.11.021. Epub 2020 Nov 22.
7
What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland.哪些因素会影响丹毒患者的住院时间?波兰下西里西亚地区 10 年回顾性研究。
Adv Clin Exp Med. 2021 Sep;30(9):981-985. doi: 10.17219/acem/136504.
8
Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis.与因下肢蜂窝织炎的主要诊断入院的患者出院天数相关的临床特征。
J Am Acad Dermatol. 2017 Apr;76(4):626-631. doi: 10.1016/j.jaad.2016.11.063. Epub 2017 Jan 12.
9
Clinical characteristics affecting length of stay in patients with cellulitis.影响蜂窝织炎患者住院时间的临床特征。
ANZ J Surg. 2019 Jan;89(1-2):90-95. doi: 10.1111/ans.14413. Epub 2018 Feb 7.
10
Risk stratification and outcome of cellulitis admitted to hospital.住院患者蜂窝织炎的风险分层和结局。
J Infect. 2010 Jun;60(6):431-9. doi: 10.1016/j.jinf.2010.03.014. Epub 2010 Mar 25.

引用本文的文献

1
Morbidity diagnosed in an internal medicine department of a secondary care center (Msaken, Sousse, Tunisia).在一家二级保健中心(突尼斯苏塞的 Msaken)的内科部门诊断出的发病率。
Tunis Med. 2021 Jan;99(1):89-105.